Worldwide Hepatitis Diagnostic Tests Industry to 2026 - Featuring Siemens, Abbott Laboratories and MedMira Among Others

News provided by

May 27, 2021, 19:00 ET

DUBLIN, May 27, 2021 /PRNewswire/ --

The "Hepatitis Diagnostic Tests Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

The global hepatitis diagnostic tests market reached a value of US$ 4.18 Billion in 2020. Hepatitis represents a major global health threat that requires an urgent response. According to estimates, hepatitis causes 1.3 Million-1.5 Million deaths each year, a figure that is comparable to the deaths caused by tuberculosis and even higher than those caused by HIV. Moreover, while mortality from diseases such as HIV, tuberculosis, and malaria are now declining, mortality from hepatitis has been rising.

According to estimates around 325-350 Million people across the globe are carriers of hepatitis B or C virus infections, which may remain asymptomatic for decades. Moreover, every year, around 1.75 Million people get infected by the hepatitis C virus infection. Unless these people receive timely testing and treatment, they are at risk of severe liver disease and even death. Diagnostic tests help in the early detection of hepatitis infections and increase the chances of survival of the patient by correct medication and treatment.

The global demand of hepatitis diagnostic tests is currently exhibiting strong growth. This market is currently being catalyzed by a number of factors such as the increasing burden of hepatitis across the globe, rising number of blood transfusions and donations, technological advancements and the advantages offered by PoC (Point of Care) test, and rising awareness levels. A major trend being witnessed in this market has been a shift from conventional testing methods to molecular diagnostics. This has resulted in an increased accuracy and reduced the total time required to get the results. Looking forward, the publisher expects the global hepatitis diagnostic tests market to exhibit moderate growth during the next five years.

Based on the test type, the market has been segmented into blood tests, imaging test and liver biopsy. Blood tests currently represent the biggest application. Blood tests are further segmented into liver function test, immunoassays, and nucleic acid tests. Liver function tests currently represent the biggest segment.

Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa and Latin America. Amongst these, North America is the biggest market, accounting for the majority of the global market.

The competitive landscape of the market has also been examined with some of the key players being Siemens AG, Abbott Laboratories, MedMira Inc, Qaigen Inc, Beckman Coulter Inc (Danaher Corporation), F. Hoffmann Roche, Diasorin S.p.A, bioMeriuex, Hologic Inc and Bio-Rad Laboratories Inc.

Key Questions Answered in This Report:

How has the global hepatitis diagnostic tests market performed so far and how will it perform in the coming years?
What are the key regional markets in the global hepatitis diagnostic tests industry?
What has been the impact of COVID-19 on the global hepatitis diagnostic tests industry?
What is the breakup of the global hepatitis diagnostic tests market on the basis of test type?
What are the various stages in the value chain of the global hepatitis diagnostic tests market?
What are the key driving factors and challenges in the global hepatitis diagnostic tests market?
What is the structure of the global hepatitis diagnostic tests market and who are the key players?
What is the degree of competition in the global hepatitis diagnostic tests market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Hepatitis Diagnostic Tests Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Test Type
5.5 Market Breakup by Region
5.6 Market Forecast
5.7 SWOT Analysis
5.7.1 Overview
5.7.2 Strengths
5.7.3 Weaknesses
5.7.4 Opportunities
5.7.5 Threats
5.8 Value Chain Analysis
5.9 Porters Five Forces Analysis
5.9.1 Overview
5.9.2 Bargaining Power of Buyers
5.9.3 Bargaining Power of Suppliers
5.9.4 Degree of Competition
5.9.5 Threat of New Entrants
5.9.6 Threat of Substitutes
5.10 Price Analysis

6 Market Breakup by Test Type
6.1 Blood Tests
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Imaging Test
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Liver Biopsy
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Region
7.1 North America
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Asia Pacific
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Europe
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Middle East and Africa
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Latin America
7.5.1 Market Trends
7.5.2 Market Forecast

8 Competitive Landscape
8.1 Market Structure
8.2 Key Players
8.3 Profiles of Key Players
8.3.1 Siemens AG
8.3.2 Abbott Laboratories
8.3.3 MedMira Inc
8.3.4 Qaigen Inc
8.3.5 Beckman Coulter Inc (Danaher Corporation)
8.3.6 F. Hoffmann Roche
8.3.7 Diasorin S.p.A
8.3.8 bioMeriuex
8.3.9 Hologic Inc
8.3.10 Bio-Rad Laboratories Inc

For more information about this report visit https://www.researchandmarkets.com/r/li0jfc

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets